Tabrecta (Capmatinib)

  • Brand Name: Tabrecta
  • Innovator Brand Name: Tabrecta
  • API: Capmatinib
  • Dosage Form: 56 Tablets
  • Strength: 150/200mg
  • Manufacturer Name: Novartis
Get Price

Description

Tabrecta Uses

Tabrecta (Capmatinib) is a kinase inhibitor used for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to MET (Mesenchymal-Epithelial Transition) exon 14 skipping as detected by an FDA-approved test.

Dosage: The recommended dosage of Capmatinib is 400 mg orally twice daily with or without food. Swallow the Capmatinib tablets whole. Do not break, crush or chew the tablets. If a patient misses or vomits a dose, instruct the patient not to make up the dose, but to take the next dose at its scheduled time.

Side Effects: The most commonly reported capmatinib side effects (≥ 20%) include:

  • peripheral edema
  • nausea,
  • fatigue
  • vomiting
  • dyspnea
  • decreased appetite

Warnings and Precautions:

  • Monitor patients with capmatinib dose for new or worsening pulmonary symptoms indicative of ILD/pneumonitis (e.g., dyspnea, cough, fever).
  • Monitor liver function tests (including ALT, AST, and total bilirubin) before initiating capmatinib fda label drug, every two weeks during the first 3 months of treatment, then once a month.
  • Patients taking treatment with capmatinib should use precautionary measures against ultraviolet exposure such as use of sunscreen or protective clothing while on treatment.
  • The capmatinib 200 mg tablet can cause fetal harm if administered to a pregnant woman. Females of reproductive age must inform their health specialist of a known or suspected pregnancy.
  • Respective women should not breastfeed during treatment with capmatinib 150 mg and for one week after the last dose.

More info

Storage: Dispense Capmatinib in the original package with the desiccant cartridge. Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F). Protect from moisture. Discard any unused capmatinib tablets remaining after 6 weeks of first opening the bottle.

Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the TABRECTA at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the TABRECTA Tablets.

Buying Procedure: In order to buy TABRECTA, you can contact us at our TOLL-FREE Number: 1800 889 1064 or on WhatsApp number +919650877511 or an Email to us at: info@theindianpharma.com along with the legitimate ID Proof, Standard Prescription and Medical Reports.

Conclusions: The Capmatinib therapy demonstrated substantial antitumor activity in adult patients with advanced non-small cell lung cancer (NSCLC) with a MET exon 14 skipping mutation, especially in those not treated previously.

FAQ

What is Tabrecta?
Tabrecta tablets is a prescription medication used to treat adults with a kind of lung cancer named non-small cell lung cancer (NSCLC) that has spread to other parts of the body or cannot be eliminated by surgery (metastatic), and whose tumors have an abnormal mesenchymal-epithelial transition (MET) gene.

When was Tabrecta FDA approved?
In May 2020, Tabrecta was approved by the US Food and Drug Administration..

What does Tabrecta contain as an active substance?
The medication Tabrecta specifically contains the active substance Capmatinib.

How much does tabrecta cost?
The tabrecta price in India usually can vary depending on the wholesaler/pharmacy you visit. Tabrecta is available as a brand name drug only, a generic version is not yet available.

What is the best price for Capmatinib?
Please contact Toll-free: +91 1800 889 1064 |+919650877511 for capmatinib price in India. We take the guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Can I get Tabrecta (Capmatinib) even if I am not based in India?
The Indian Pharma helps patients in accessing or importing Tabrecta (Capmatinib), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.

Reviews

There are no reviews yet.

Be the first to review “Tabrecta (Capmatinib)”

Your email address will not be published.

×